Alexander Kabanov, PhD, DrSci, has been elected to the American Institute for Medical and Biological Engineering’s College of Fellows, an honor reserved for the top two percent of medical and biological engineers.
Kabanov was nominated, reviewed, and elected by peers and members of the College of Fellows for seminal works on polymeric nanosystems for drug delivery that have considerably influenced current ideas and approaches in nanomedicine, according to AIMBE.
Kabanov is the Mescal Swaim Ferguson Distinguished Professor in the Division of Chemical Biology and Medicinal Chemistry at the UNC Eshelman School of Pharmacy and director of the School’s Center for Nanotechnology in Drug Delivery. He is codirector of the Carolina Institute for Nanomedicine at the University of North Carolina at Chapel Hill and a member of the UNC Lineberger Comprehensive Cancer Center.
The AIMBE is a nonprofit organization created in 1991 to advocate the importance of medical and biological engineering in America. The organization’s College of Fellows represents approximately 1,000 individuals who have distinguished themselves in the field of medical and biological engineering through research, industrial practice, or education.
Kabanov’s pioneering research includes work with polymeric micelles, DNA/polycation complexes, block ionomer complexes, and nanogels for delivery of small drugs, nucleic acids and proteins. His research has been influential in the field of drug delivery and nanomedicine. This has resulted in numerous honors, including membership in the Academia Europaea.
Kabanov has published more than 240 scientific papers and has more than 100 patents worldwide. His work has been cited over 16,700 times, putting him on the Thomson Reuters’s 2014 Highly Cited Researchers List.
Prior to joining UNC-Chapel Hill in July 2012, Kabanov served on the faculty of the University of Nebraska Medical Center for nearly eighteen years. At UNMC he was the Parke-Davis Professor of Pharmaceutical Sciences and director of the Center for Drug Delivery and Nanomedicine, which he founded in 2004.
Kabanov received his PhD in chemical kinetics and catalysis in 1987 at Moscow State University.
By Aren Besson